I don’t understand why anyone would be selling now if they don’t need the money, unless you’re trading it down of course. The stock is down considerably and it’s times like this when the risk/reward skews more towards the reward side imo.
look I’ve been disappointed about the sp action- who hasn’t. But the company did just start p2 and also throughout the last two years raised a considerable amount of money- ~55m from memory. Selling at .014 is literally selling at the low. I may have even bought someone’s shares at .014 and will again at .013 and .012 if it gets there.
People have to remember- this is a biotech startup. It will take everything the company has to develop a single compound safe for human use and it will take a long time. I can only HOPE that the company is doing everything they can to optimise and reinforce their p2 trial. And also, the company also has to be valued reasonably. What that number is though is anyones guess. Turds can go lower though, so it may go further down as well. But that is why you have money on the sidelines to buy. I think when buying into a stock like Ath, you must have a very long horizon in terms of times to invest. That way you can get good prices if the company ever makes it.
Let the stock gods give us mercy but above all, health, happiness and prosperity. Everything which Ath could deliver. COULD…..
Gltah and dyor
ATH Price at posting:
1.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)